foscarnet has been researched along with Blood Diseases in 2 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Foscarnet is an active agent against cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT), as well as ganciclovir." | 1.36 | Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. ( Asakura, M; Atsuta, Y; Etoh, T; Fukuda, T; Hatanaka, K; Ikegame, K; Kanamori, H; Mori, T; Ogawa, H; Sakamaki, H; Suzuki, R; Takami, A; Taniguchi, S; Yoshida, T; Yoshihara, S; Yujiri, T, 2010) |
| " Surprisingly, AZT significantly increased serum creatinine levels on Days 5 and 11 of treatment (up to 40% increase), whereas PFA was less toxic (only approximately 17% increase on Day 5 of treatment)." | 1.29 | In vivo toxicity of foscarnet and zidovudine given alone or in combination. ( Beauchamp, D; Bergeron, MG; Désormeaux, A; Gourde, P; Omar, RF; Tremblay, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakura, M | 1 |
| Ikegame, K | 1 |
| Yoshihara, S | 1 |
| Taniguchi, S | 1 |
| Mori, T | 1 |
| Etoh, T | 1 |
| Takami, A | 1 |
| Yoshida, T | 1 |
| Fukuda, T | 1 |
| Hatanaka, K | 1 |
| Kanamori, H | 1 |
| Yujiri, T | 1 |
| Atsuta, Y | 1 |
| Sakamaki, H | 1 |
| Suzuki, R | 1 |
| Ogawa, H | 1 |
| Omar, RF | 1 |
| Gourde, P | 1 |
| Désormeaux, A | 1 |
| Tremblay, M | 1 |
| Beauchamp, D | 1 |
| Bergeron, MG | 1 |
2 other studies available for foscarnet and Blood Diseases
| Article | Year |
|---|---|
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.
Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Drug Evaluation; Family; Female; Foscarnet; Gan | 2010 |
In vivo toxicity of foscarnet and zidovudine given alone or in combination.
Topics: Animals; Antiviral Agents; Female; Foscarnet; Hematologic Diseases; Injections, Intraperitoneal; Kid | 1996 |